| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51662-1385-1 | 51662-1385 | HUMAN PRESCRIPTION DRUG | NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | INJECTION, SOLUTION | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS | 20191015 | N/A | ANDA | ANDA070257 | HF Acquisition Co LLC, DBA HealthFirst | NALOXONE HYDROCHLORIDE | .4 mg/mL | 1 VIAL, MULTI-DOSE in 1 CARTON (51662-1385-1) / 10 mL in 1 VIAL, MULTI-DOSE |
| 0409-1219-01 | 0409-1219 | HUMAN PRESCRIPTION DRUG | Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | INJECTION, SOLUTION | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS | 20050902 | N/A | ANDA | ANDA070257 | Hospira, Inc. | NALOXONE HYDROCHLORIDE | .4 mg/mL | 25 CARTON in 1 CASE (0409-1219-01) / 1 VIAL, MULTI-DOSE in 1 CARTON / 10 mL in 1 VIAL, MULTI-DOSE (0409-1219-41) |